Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the efficacy of oral vandetanib 300 mg once daily compared with vinorelbine administrated intravenously weekly in patients with inoperable or relapsed malignant mesothelioma by estimating the overall disease control rate (DCR=CR+PR+SD)
Critère d'inclusion
- Malignant Mesothelioma